Why Athersys (ATHX) Stock Skyrocketed 19% Today - Smarter Analyst

Why Athersys (ATHX) Stock Skyrocketed 19% Today  Smarter Analyst

Shares of Athersys (ATHX) are skyrocketing today, up 19% in pre-market trading, after the clinical-stage biotech announced encouraging summary results.



Comments

Post a Comment

Popular posts from this blog

“Diagnosis and management of acute respiratory distress syndrome - CMAJ” plus 2 more

Image
“Diagnosis and management of acute respiratory distress syndrome - CMAJ” plus 2 more Diagnosis and management of acute respiratory distress syndrome - CMAJ Underlying illness, respiratory infection raise risk for severe COVID in kids - CIDRAP COPD lung sounds: Types, descriptions, treatment, and more - Medical News Today Diagnosis and management of acute respiratory distress syndrome - CMAJ Posted: 25 May 2021 12:00 AM PDT KEY POINTS Acute respiratory distress syndrome (ARDS) can arise from a variety of causes, and manifests clinically as acute hypoxemic respiratory failure, characterized by acute, diffuse, inflammatory lung injury that leads to increased alveolar capillary permeability and development of nonhydrostatic pulmonary edema. Clinical diagnosis of ARDS is made on the basis of the Berlin definition, with severity of the disease and prognosis for survival based on the degree of hypoxemia. ...
Read more